HPGD Antikörper (AA 55-160)
-
- Target Alle HPGD Antikörper anzeigen
- HPGD (Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD))
-
Bindungsspezifität
- AA 55-160
-
Reaktivität
- Human, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser HPGD Antikörper ist unkonjugiert
-
Applikation
- ELISA, Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Kreuzreaktivität
- Human, Ratte
- Homologie
- Mouse,Cow,Pig,Horse,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human Prostaglandin dehydrogenase 1
- Isotyp
- IgG
- Top Product
- Discover our top product HPGD Primärantikörper
-
-
- Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
-
15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer." in: International journal of clinical and experimental pathology, Vol. 8, Issue 6, pp. 6910-8, (2015) (PubMed).
: "15-PGDH/15-KETE plays a role in hypoxia-induced pulmonary vascular remodeling through ERK1/2-dependent PAR-2 pathway." in: Cellular signalling, Vol. 26, Issue 7, pp. 1476-1488, (2014) (PubMed).
: "
-
15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer." in: International journal of clinical and experimental pathology, Vol. 8, Issue 6, pp. 6910-8, (2015) (PubMed).
-
- Target
- HPGD (Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD))
- Andere Bezeichnung
- Prostaglandin Dehydrogenase 1 (HPGD Produkte)
- Synonyme
- CBR antikoerper, SDR21C1 antikoerper, hCBR1 antikoerper, 15-PGDH antikoerper, PGDH antikoerper, PGDH1 antikoerper, PHOAR1 antikoerper, SDR36C1 antikoerper, MGC80546 antikoerper, MGC79454 antikoerper, AV026552 antikoerper, carbonyl reductase 1 antikoerper, 15-hydroxyprostaglandin dehydrogenase antikoerper, hydroxyprostaglandin dehydrogenase 15-(NAD) antikoerper, 15-hydroxyprostaglandin dehydrogenase L homeolog antikoerper, hydroxyprostaglandin dehydrogenase 15 (NAD) antikoerper, CBR1 antikoerper, HPGD antikoerper, hpgd.L antikoerper, hpgd antikoerper, pgdh antikoerper, Hpgd antikoerper, PTRG_03214 antikoerper, VDBG_09957 antikoerper
- Hintergrund
-
Synonyms: PGDH, PGDH1, PHOAR1, 15-PGDH, SDR36C1, 15-hydroxyprostaglandin dehydrogenase [NAD(+)], Prostaglandin dehydrogenase 1, HPGD
Background: Prostaglandin inactivation. Contributes to the regulation of events that are under the control of prostaglandin levels. Catalyzes the NAD-dependent dehydrogenation of lipoxin A4 to form 15-oxo-lipoxin A4. Inhibits in vivo proliferation of colon cancer cells.
- Gen-ID
- 3248
- UniProt
- P15428
-